Letter to the Editor: The real-world effectiveness of lamotrigine as a mood stabilizer for those with a bipolar II disorder: A pragmatic research study

Abbasi AB Curtis LH Califf RM (2024) Why should the FDA focus on pragmatic clinical research? Journal of the American Medical Association 33: 203–104.

Parker G (2018) Risks associated with lamotrigine prescription: A review and personal observations. Australasian Psychiatry 26: 640–642.

Parker G McCraw S (2015) The ‘disconnect’ between initial judgments of lamotrigine vs. its real-world effectiveness in managing bipolar disorder. A tale with wider ramifications. Acta Psychiatrica Scandinavica 132: 345–354.

Post R (2019) Management commentary. In: Parker G (ed.) Bipolar II Disorder. Modelling, Measuring and Managing, 3rd Edition. Cambridge: Cambridge University Press, pp. 255–262.

Wang XQ Xiong J Xu WH , et al. (2015) Risk of a lamotrigine-related skin rash: Current meta-analysis and postmarketing cohort analysis. Seizure 25: 52–61.